Astellas Institute For

AVI BioPharma is a biopharmaceutical company that develops drugs to treat life-threatening diseases using its patented third generation antisense technology. It has completed clinical trials with its NeuGene antisense drugs in more than 300 subjects, addressing cardiovascular restenosis, infectious diseases, cancer, polycystic kidney disease and drug metabolism. Its most advanced cardiovascular program is for restenosis, where it has completed Phase II trials, evaluating its drug, Resten-NG. AVI BioPharma is also in a Phase II clinical trial with a drug for Hepatitis C infection and its influenza A drug candidate has been confirmed to have efficacy against avian influenza H5N1 in preclinical studies. AVI BioPharma maintains a location in Portland, Ore.

Wyzer Biosciences is a cutting-edge biotechnology company based in Cambridge, MA, specializing in innovative research and development within the life sciences industry. With a focus on advancing technologies and solutions in the field of biosciences, Wyzer Biosciences is dedicated to pushing the boundaries of scientific discovery and driving progress in healthcare and beyond. Generated from their business information

Agios Pharmaceuticals, Inc, based in Cambridge, has prioritized patients and scientific advancement throughout its 12-year history. With a strong foundation of values and competencies, Agios focuses on developing innovative therapies that make a meaningful impact on patient care. By leveraging their core strengths and commitment to differentiation, Agios Pharmaceuticals continues to drive positive change in the medical field. Their unwavering dedication to patients and scientific excellence ensures a promising future of continued impact and growth. Generated from their website's infomation